Wayne I. Roe
President at Entrack, Inc.
Profile
Wayne I.
Roe was the founder of Covance Health Economics & Outcomes Services, Inc. founded in 1988 where he held the title of Chairman in 1999.
He currently holds director positions at ADERIS Pharmaceuticals, Inc., Fe3 Medical, Inc., Velocity Pharmaceutical Development LLC, Maryland Angels Fund, and is the Managing Director at InCube Venture Partners LLC since 2008.
Mr. Roe has held former director positions at Aradigm Corp., ISTA Pharmaceuticals, Inc., IntraPace, Inc., Favrille, Inc., Celera Corp., Gemin X Pharmaceuticals US, Inc., and HemaQuest Pharmaceuticals, Inc. He was also the Senior Vice President at United Therapeutics Corp.
from 1999 to 2000 and Vice President-Economic & Health Policy at Health Industry Manufacturers Association.
Mr. Roe has an undergraduate degree from Union College (New York) and graduate degrees from the University of Maryland and The State University of New York.
Wayne I. Roe active positions
| Companies | Position | Start |
|---|---|---|
ADERIS Pharmaceuticals, Inc.
 ADERIS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ADERIS Pharmaceuticals, Inc. develops and commercializes drugs and pharmaceuticals. It engages in small molecule drug development to treat central nervous system, cardiovascular, and inflammatory disorders. The company was founded by Donald McAfee, Noel Cusack, Gevork I. Minaskanian, and Peter Savasand in 1994 and is headquartered in Hopkinton, MA. | Director/Board Member | - |
| Maryland Angels Fund | Corporate Officer/Principal | - |
InCube Venture Partners LLC
 InCube Venture Partners LLC Investment ManagersFinance InCube Ventures Partners LLC (InCube Ventures) is a venture capital firm founded in 2008 by Mir Imran. The firm is headquartered in San Jose, California. | Private Equity Investor | 2008-06-30 |
Fe3 Medical, Inc.
 Fe3 Medical, Inc. Medical SpecialtiesHealth Technology Fe3 Medical, Inc. develops a transdermal therapy for iron deficiency anemia. It offers a disposable transdermal patch that delivers the amount of iron needed directly through the skin, bypassing the GI tract and eliminating undesirable side effects. The company was founded by Mir A. Imran in 2008 and is headquartered in San Antonio, TX. | Director/Board Member | 2011-05-19 |
Entrack, Inc.
 Entrack, Inc. Medical SpecialtiesHealth Technology Entrack, Inc. specializes in the development of novel treatment solutions for the diagnosis and treatment of gastrointestinal diseases. The firm operates as a medical technology venture company, with focus on the development of gastric stimulators for the treatment of obesity-related conditions and disorders. The company was founded in 2001 and is headquartered in San Jose, CA. | President | - |
Velocity Pharmaceutical Development LLC
 Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA. | Director/Board Member | - |
Former positions of Wayne I. Roe
| Companies | Position | End |
|---|---|---|
Celera Corp.
 Celera Corp. Medical/Nursing ServicesHealth Services Celera Corp. provides medical diagnostics services. It offers disease management solutions through a combination of tests and services based on genetics discovery platforms. Celera was founded in 1998 and is headquartered in Alameda, CA. | Director/Board Member | 2011-05-02 |
| Favrille, Inc. | Director/Board Member | 2009-04-21 |
ISTA Pharmaceuticals, Inc.
 ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Director/Board Member | 2002-10-30 |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Training of Wayne I. Roe
| Union College (New York) | Undergraduate Degree |
| University of Maryland | Graduate Degree |
| The State University of New York | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| Private companies | 15 |
|---|---|
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA. | Health Technology |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Health Technology |
ADERIS Pharmaceuticals, Inc.
ADERIS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ADERIS Pharmaceuticals, Inc. develops and commercializes drugs and pharmaceuticals. It engages in small molecule drug development to treat central nervous system, cardiovascular, and inflammatory disorders. The company was founded by Donald McAfee, Noel Cusack, Gevork I. Minaskanian, and Peter Savasand in 1994 and is headquartered in Hopkinton, MA. | Health Technology |
IntraPace, Inc.
 IntraPace, Inc. Medical SpecialtiesHealth Technology IntraPace, Inc. develops systems for the treatment of obesity. These also track patient activity levels, providing an overview of food consumption and exercise trends. The company was founded in 2001 and is headquartered in San Jose, CA. | Health Technology |
| Favrille, Inc. | Health Technology |
Celera Corp.
Celera Corp. Medical/Nursing ServicesHealth Services Celera Corp. provides medical diagnostics services. It offers disease management solutions through a combination of tests and services based on genetics discovery platforms. Celera was founded in 1998 and is headquartered in Alameda, CA. | Health Services |
Fe3 Medical, Inc.
Fe3 Medical, Inc. Medical SpecialtiesHealth Technology Fe3 Medical, Inc. develops a transdermal therapy for iron deficiency anemia. It offers a disposable transdermal patch that delivers the amount of iron needed directly through the skin, bypassing the GI tract and eliminating undesirable side effects. The company was founded by Mir A. Imran in 2008 and is headquartered in San Antonio, TX. | Health Technology |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Health Technology |
HemaQuest Pharmaceuticals, Inc.
 HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA. | Health Technology |
| Maryland Angels Fund | |
| Health Industry Manufacturers Association | |
InCube Venture Partners LLC
InCube Venture Partners LLC Investment ManagersFinance InCube Ventures Partners LLC (InCube Ventures) is a venture capital firm founded in 2008 by Mir Imran. The firm is headquartered in San Jose, California. | Finance |
Velocity Pharmaceutical Development LLC
Velocity Pharmaceutical Development LLC Drugstore ChainsRetail Trade Velocity Pharmaceutical Development LLC develops pharmaceutical drugs. It identifies drug candidates, target markets and designing and managing outsourced clinical trials. The firm seeks to acquire promising drug candidates, generally within a year of their entering human clinical trials or after initial human clinical data have been generated. The company was founded by David Collier, Ed Schnipper, Jim Larrick and Andy Perlman in 2011 and is headquartered in South San Francisco, CA. | Retail Trade |
Entrack, Inc.
Entrack, Inc. Medical SpecialtiesHealth Technology Entrack, Inc. specializes in the development of novel treatment solutions for the diagnosis and treatment of gastrointestinal diseases. The firm operates as a medical technology venture company, with focus on the development of gastric stimulators for the treatment of obesity-related conditions and disorders. The company was founded in 2001 and is headquartered in San Jose, CA. | Health Technology |
| Covance Health Economics & Outcomes Services, Inc. |
- Stock Market
- Insiders
- Wayne I. Roe
